本頁面由Tiger Trade Technology Pte. Ltd.提供服務

眾巢醫學

9.90
+8.43573.47%
成交量:9,411.49萬
成交額:7.15億
市值:40.99萬
市盈率:-0.06
高:11.96
開:2.26
低:2.13
收:1.47
52周最高:31.20
52周最低:0.0714
股本:4.14萬
流通股本:4.14萬
量比:1,892.06
換手率:227330.67%
股息:- -
股息率:- -
每股收益(TTM):-171.6768
每股收益(LYR):-57.3500
淨資產收益率:-24.88%
總資產收益率:-15.47%
市淨率:0.02
市盈率(LYR):-0.17

資料載入中...

2026/06/05

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/22

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/05/07

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2026/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/01/15

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2025/08/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/07/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/21

SEC問詢函

Form CORRESP - Correspondence
2025/06/07

SEC問詢函

Form CORRESP - Correspondence
2025/05/20

SEC問詢函

Form CORRESP - Correspondence
2025/05/07

SEC問詢函

Form CORRESP - Correspondence
2025/04/25

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/27

SEC問詢函

Form CORRESP - Correspondence
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/12

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/08

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]